Concepedia

K. Wathen

KW

3

Publications

119

Citations

3

H-Index

2004

Active since

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

K. Wathen is an author at Memorial Sloan Kettering Cancer Center specializing in oncology, pathology, and cancer therapeutics.

Top concepts

Publications per year

2004–2011

3

Publications

3

A phase II study of dasatinib for patients with imatinib-resistant gastrointestinal stromal tumor (GIST).

Jonathan C. Trent, K. Wathen, Margaret von Mehren et al. · Journal of Clinical Oncology · 2011 · 70 citations

, , +15

Results of a Sarcoma Alliance for Research through Collaboration (SARC) phase II trial of dasatinib in previously treated, high-grade, advanced sarcoma.

Scott M. Schuetze, K. Wathen, Edwin Choy et al. · Journal of Clinical Oncology · 2010 · 36 citations

Imatinib mesylate in soft tissue and bone sarcomas: Interim results of a Sarcoma Alliance for Research thru Collaboration (SARC) phase II trial

Rashmi Chugh, Dafydd G. Thomas, K. Wathen et al. · Journal of Clinical Oncology · 2004 · 13 citations

, , +16

Rows per page

1–3 of 3